In the framework of the ongoing evaluation of the EU Drugs Strategy 2021-2025 and EU Drugs Action Plan 2021-2025, the European Commission has launched a Public Consultation to collect feedback from a broad range of stakeholders including EU and non-EU citizens, academy, NGOs, private sector and public authorities amongst others.
The consultation aims to gather input on the effectiveness, efficiency, relevance, coherence and EU added value of the Strategy and Action Plan for the period covered from 2021 until now.
The consultation was launched on 3 June 2024 and will close on 26 August 2024.
Please find the link to the consultation here>>>.